• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人们对性和暴露前预防的需求。

What people want from sex and preexposure prophylaxis.

作者信息

Grant Robert M, Koester Kimberly A

机构信息

aGladstone Institutes bUniversity of California cSan Francisco AIDS Foundation, San Francisco, California, USA.

出版信息

Curr Opin HIV AIDS. 2016 Jan;11(1):3-9. doi: 10.1097/COH.0000000000000216.

DOI:10.1097/COH.0000000000000216
PMID:26569183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6446930/
Abstract

PURPOSE OF REVIEW

As demand for preexposure prophylaxis (PrEP) increases, we are learning more about what people want from sex and PrEP.

RECENT FINDINGS

PrEP demand has reached a tipping point in the USA and is increasing rapidly. Although the primary benefit of PrEP use is biological, to reduce risk of HIV infection, PrEP users often express an alternative set of social and emotional benefits that are provided by PrEP. These collateral benefits of PrEP have salience, affect, and are experienced in the present, which are compelling drivers of human behavior. PrEP use has been associated with feeling safe during sex, usually in contrast to ruminations related to fear of HIV or intimate partner violence or control. PrEP can create empowerment, or agency, defined as the capacity and autonomy to act on one's own behalf, because it provides control over one's vulnerability to HIV and relief to women and men who may otherwise worry about whether their partners will use a condom, take antiretroviral therapy, or disclose their HIV status accurately. Planning for sexual and social goals in calm moments is also empowering. These highly desired collateral benefits of PrEP could be undermined, or eliminated, if PrEP is implemented in ways that are coercive or that foment fear of sexual risk compensation, drug resistance, toxicity, or moral judgment.

SUMMARY

Current PrEP implementation provides direct and indirect benefits that are highly desired.

摘要

综述目的

随着暴露前预防(PrEP)需求的增加,我们对人们在性和PrEP方面的期望有了更多了解。

最新发现

在美国,PrEP需求已达到临界点且正在迅速增长。虽然使用PrEP的主要益处是生物学上的,即降低感染HIV的风险,但PrEP使用者常常表达出PrEP带来的一系列其他社会和情感益处。PrEP的这些附带益处具有显著性、影响力,且是当下就能体验到的,是人类行为的有力驱动因素。使用PrEP与性行为时感到安全有关,这通常与担心感染HIV、亲密伴侣暴力或控制等反复思考形成对比。PrEP可以带来赋权,即代表自己行动的能力和自主性,因为它能让人控制自身感染HIV的易感性,并让那些原本可能担心伴侣是否会使用避孕套、接受抗逆转录病毒治疗或准确披露其HIV感染状况的男女感到宽慰。在平静时刻规划性和社会目标也能带来赋权。如果以强制方式实施PrEP,或者引发对性风险补偿、耐药性、毒性或道德评判的恐惧,PrEP这些备受期待的附带益处可能会受到损害或消除。

总结

当前PrEP的实施带来了人们高度期望的直接和间接益处。

相似文献

1
What people want from sex and preexposure prophylaxis.人们对性和暴露前预防的需求。
Curr Opin HIV AIDS. 2016 Jan;11(1):3-9. doi: 10.1097/COH.0000000000000216.
2
Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?我们应该担心替诺福韦/恩曲他滨暴露前预防产生的耐药性吗?
Curr Opin HIV AIDS. 2016 Jan;11(1):49-55. doi: 10.1097/COH.0000000000000209.
3
Cost-effectiveness of preexposure prophylaxis for HIV prevention for conception in the United States.在美国,预防 HIV 暴露前预防措施对受孕的成本效益。
AIDS. 2018 Nov 28;32(18):2787-2798. doi: 10.1097/QAD.0000000000002014.
4
Nondaily preexposure prophylaxis for HIV prevention.用于预防HIV的非每日暴露前预防。
Curr Opin HIV AIDS. 2016 Jan;11(1):94-101. doi: 10.1097/COH.0000000000000213.
5
Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women.基于替诺福韦的口服暴露前预防可预防女性感染艾滋病毒。
Curr Opin HIV AIDS. 2016 Jan;11(1):18-26. doi: 10.1097/COH.0000000000000207.
6
The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA.暴露前预防的变革:从临床试验到常规实践——美国的实施视角
Curr Opin HIV AIDS. 2016 Jan;11(1):67-73. doi: 10.1097/COH.0000000000000222.
7
Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: experience from a hospital-based clinic in France.每日或按需口服替诺福韦地索普西酯/恩曲他滨用于 HIV 暴露前预防:来自法国一家医院诊所的经验。
AIDS. 2018 Sep 24;32(15):2161-2169. doi: 10.1097/QAD.0000000000001939.
8
High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.感染艾滋病毒风险较高的男男性行为者对暴露前预防的高度关注:美国暴露前预防示范项目的基线数据
J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):439-48. doi: 10.1097/QAI.0000000000000479.
9
Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.预防艾滋病病毒暴露前预防革命中关于坚持暴露前预防的当前概念:从临床试验到常规实践。
Curr Opin HIV AIDS. 2016 Jan;11(1):10-7. doi: 10.1097/COH.0000000000000220.
10
Welcome to the preexposure prophylaxis revolution.欢迎来到暴露前预防革命。
Curr Opin HIV AIDS. 2016 Jan;11(1):1-2. doi: 10.1097/COH.0000000000000225.

引用本文的文献

1
Styles of thought in healthcare governance: A situational analysis of English PrEP discourse 2016-2020.医疗保健治理中的思维方式:2016 - 2020年英国暴露前预防(PrEP)话语的情境分析
Biosocieties. 2025;20(3):520-550. doi: 10.1057/s41292-025-00351-8. Epub 2025 Apr 13.
2
Ending HIV Transmission in Australia: Expanding PrEP to Cisgender Women: A Scoping Review.在澳大利亚终结艾滋病毒传播:扩大顺性别女性的 PrEP 覆盖面:范围综述。
AIDS Behav. 2024 Sep;28(9):3038-3050. doi: 10.1007/s10461-024-04386-z. Epub 2024 May 28.
3
Interventions, Barriers, and Facilitators to Address the Sexual Problems of Gay, Bisexual and Other Men Who Have Sex with Men Living with HIV: A Rapid Scoping Review.干预措施、障碍和促进因素,以解决感染艾滋病毒的男同性恋、双性恋和其他与男性发生性关系的男性的性问题:快速范围综述。
AIDS Behav. 2024 Feb;28(2):450-472. doi: 10.1007/s10461-023-04237-3. Epub 2024 Jan 31.
4
Application of Bayesian networks to identify factors influencing acceptability of HIV pre-exposure prophylaxis in Guilin, China.贝叶斯网络在中国桂林识别影响 HIV 暴露前预防可接受性因素的应用。
Sci Rep. 2022 Nov 29;12(1):20542. doi: 10.1038/s41598-022-24965-1.
5
Beyond HIV prevention: Additional individual and community-level benefits of PrEP among Latino gay and bisexual men.超越艾滋病毒预防:拉美裔男同性恋和双性恋者中 PrEP 的额外个人和社区层面的益处。
PLoS One. 2022 Jun 13;17(6):e0269688. doi: 10.1371/journal.pone.0269688. eCollection 2022.
6
High Rates of Pre-exposure Prophylaxis Eligibility and Associated HIV Incidence in a Population With a Generalized HIV Epidemic in Rakai, Uganda.在乌干达拉凯,普遍存在 HIV 流行的人群中,较高的暴露前预防资格率和相关的 HIV 发病率。
J Acquir Immune Defic Syndr. 2022 Jul 1;90(3):291-299. doi: 10.1097/QAI.0000000000002946. Epub 2022 Mar 8.
7
Pleasure and PrEP: A Systematic Review of Studies Examining Pleasure, Sexual Satisfaction, and PrEP.性愉悦与 PrEP:系统回顾研究性愉悦、性满足与 PrEP 关系
J Sex Res. 2022 Sep;59(7):848-861. doi: 10.1080/00224499.2021.2012638. Epub 2022 Jan 28.
8
Exploring the Shift From HIV Pre-exposure Prophylaxis Awareness to Uptake Among Young Gay and Bisexual Men.探索年轻男同性恋和双性恋者中 HIV 预防前意识向接受度的转变。
Front Public Health. 2021 Dec 7;9:677716. doi: 10.3389/fpubh.2021.677716. eCollection 2021.
9
Roll-out of HIV pre-exposure prophylaxis: a gateway to mental health promotion.推广艾滋病病毒暴露前预防:促进心理健康的途径。
BMJ Glob Health. 2021 Dec;6(12). doi: 10.1136/bmjgh-2021-007212.
10
Sex-Positivity, Medical Mistrust, and PrEP Conspiracy Beliefs Among HIV-Negative Cisgender Black Sexual Minority Men in Atlanta, Georgia.佐治亚州亚特兰大市 HIV 阴性顺性别黑人男同性恋者中的性积极、医疗不信任和暴露前预防(PrEP)阴谋信念。
Arch Sex Behav. 2022 Jul;51(5):2571-2581. doi: 10.1007/s10508-021-02174-7. Epub 2021 Nov 10.

本文引用的文献

1
No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.在临床实践环境中,随着艾滋病病毒暴露前预防措施使用的增加,新的艾滋病病毒感染病例未出现增长。
Clin Infect Dis. 2015 Nov 15;61(10):1601-3. doi: 10.1093/cid/civ778. Epub 2015 Sep 1.
2
Rethinking HIV prevention to prepare for oral PrEP implementation for young African women.重新思考艾滋病预防策略,为非洲年轻女性实施口服暴露前预防做准备。
J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):20227. doi: 10.7448/IAS.18.4.20227. eCollection 2015.
3
Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda.针对乌干达坎帕拉高危血清学不一致夫妇的暴露前预防作为持续使用抗逆转录病毒疗法的桥梁的成本效益。
J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):20013. doi: 10.7448/IAS.18.4.20013. eCollection 2015.
4
Beyond "getting drugs into bodies": social science perspectives on pre-exposure prophylaxis for HIV.超越“将药物输送到体内”:关于艾滋病病毒暴露前预防的社会科学视角
J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):19983. doi: 10.7448/IAS.18.4.19983. eCollection 2015.
5
Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm.界定艾滋病病毒暴露前预防的成功:一种预防有效依从性范式。
AIDS. 2015 Jul 17;29(11):1277-85. doi: 10.1097/QAD.0000000000000647.
6
Ending sexual HIV transmission: lessons learned from perinatal HIV.终结性传播艾滋病毒感染:围产期艾滋病毒感染的经验教训
J Assoc Nurses AIDS Care. 2015 Sep-Oct;26(5):520-5. doi: 10.1016/j.jana.2015.05.005. Epub 2015 Jun 19.
7
Acceptability of drug detection monitoring among participants in an open-label pre-exposure prophylaxis study.开放标签暴露前预防研究参与者对药物检测监测的可接受性。
AIDS Care. 2015;27(10):1199-204. doi: 10.1080/09540121.2015.1039958. Epub 2015 May 22.
8
Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling Notes.旧金山暴露前预防示范项目参与者的性行为、风险补偿与艾滋病病毒预防策略:咨询记录的定性分析
AIDS Behav. 2016 Jul;20(7):1461-9. doi: 10.1007/s10461-015-1055-5.
9
Tenofovir-based preexposure prophylaxis for HIV infection among African women.基于替诺福韦的暴露前预防用于非洲女性的HIV感染
N Engl J Med. 2015 Feb 5;372(6):509-18. doi: 10.1056/NEJMoa1402269.
10
HIV prevention through the lens of behavioral economics.从行为经济学视角看艾滋病病毒预防
J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):e61-3. doi: 10.1097/QAI.0000000000000499.